Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)

Documenti analoghi

• Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV
  di: Kyle Ring, et al.
  Pubblicazione: (2025)
• Commentary on ‘Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI‐net)’
  di: Sanjit Sah, et al.
  Pubblicazione: (2024)
• Outcomes of real‐world initiation of long‐acting injectable cabotegravir and rilpivirine ( LA ‐I CAB  +  RPV ) in individuals with viraemia: A systematic review of baseline characteristics, virological failure outcomes and discontinuations
  di: Alexa Elias, et al.
  Pubblicazione: (2025)
• Longitudinal monitoring of cabotegravir and rilpivirine exposure from hair strand concentrations
  di: E. Rosen, et al.
  Pubblicazione: (2025)
• Pharmacokinetics of long‐acting cabotegravir and rilpivirine in seminal plasma throughout the dosing interval
  di: N. Neverette, et al.
  Pubblicazione: (2025)